Mylan Laboratories Limited Ritonavir Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Ritonavir Export Records India — #2 Exporter, 550 Shipments, $27.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ritonavir

India Pharmaceutical Trade Intelligence

$340.6M84 Suppliers155 CountriesHS 30049099

ExportsIndia → BELGIUM51.5%India → INDONESIA7.8%

ImportsUNITED STATES → India$92.3K BRAZIL → India$80.0K

#1 Supplier: HETERO LABS

Mylan Laboratories Limited — Ritonavir Exporter #2 | $27.5M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Ritonavir Exporter Profile

Indian Pharmaceutical Exporter · #2 for Ritonavir · $27.5M export value · DGFT Verified

Mylan Laboratories Limited is the #2 Indian exporter of Ritonavir with $27.5M in export value and 550 verified shipments. Mylan Laboratories Limited holds a 8.1% market share in Ritonavir exports across 92 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Ritonavir Export Profile: Buyers & Destinations

Mylan Laboratories Limited Ritonavir export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Ritonavir?

Country	Value	Shipments	Share
SOUTH AFRICA	$2.0M	46	14.7%
NIGERIA	$1.3M	26	9.7%
NETHERLANDS	$733.5K	46	5.5%
THAILAND	$715.1K	18	5.4%

Who Are the Top Buyers of Ritonavir from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
USAID,	NIGERIA	$1.0M	21
NATIONAL MEDICAL STORES	UGANDA	$501.0K	15
VIATRIS HEALTHCARE PTY LTD	SOUTH AFRICA	$350.0K	7
VIATRIS HEALTHCARE PTY LIMITED KEMPTON PARK	SOUTH AFRICA	$350.0K	7
XXATRXX HEXXTHCXXE (XXY) XXD XXMPTXX PAXX	SOUTH AFRICA	$350.0K	7
VIATRIS HEALTHCARE (PTY) LTD,	SOUTH AFRICA	$341.6K	10
SAI PHARMA CO LTD	THAILAND	$300.0K	6
MYLAN IRELAND C O ALLOGA RDC	NETHERLANDS	$286.9K	17
VIATRIS HEALTHCARE (PTY) LTD	SOUTH AFRICA	$277.3K	6
COMMERCIAL BANK OF ETHIOPIA	ETHIOPIA	$271.8K	10

Mylan Laboratories Limited supplies Ritonavir to 224 buyers globally. The largest buyer is USAID, (NIGERIA), followed by NATIONAL MEDICAL STORES (UGANDA) and VIATRIS HEALTHCARE PTY LTD (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ritonavir Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
ANZAVIR-R(Atazanavir 300Mg + Ritonavir 1	$408.8K	10
ATAZANAVIR 300MG + RITONAVIR 100MG) TABL	$395.0K	17
RILOVIA LOPINAVIR 200 MG + RITONAVIR	$350.0K	7
(RILOVIA) LOPINAVIR 200 MG + RITONAVIR	$350.0K	7
LOPINAVIR 200MG + RITONAVIR 50MG	$345.3K	7
LOPINAVIR 200MG + RITONAVIR 50MG TABLETS	$249.5K	6
RITONAVIR PREMIX	$200.0K	4
Ritonavir 100Mg Tablets (30s) - No Cart	$200.0K	4
LOPINAVIR 200 MG + RITONAVIR 50 MG TABLE	$175.3K	6
ANZAVIR-R (ATAZANAVIR 300MG + RITONAVIR	$166.4K	11

Mylan Laboratories Limited exports 312 distinct Ritonavir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ANZAVIR-R(Atazanavir 300Mg + Ritonavir 1 with 10 shipments worth $408.8K.

How Does Mylan Laboratories Limited Compare to Nearest Ritonavir Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MYLAN LABORATORIES LIMITED ★	$27.5M	550	92	$50.0K
1	HETERO LABS LIMITED	$24.7M	494	81	$50.0K
4	EMCURE PHARMACEUTICALS LIMITED	$5.5M	110	43	$50.0K

Mylan Laboratories Limited ranks #2 among 84 Indian Ritonavir exporters. Average shipment value of $50.0K compared to the market average of $823.4K. The closest competitors by value are HETERO LABS LIMITED and EMCURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Ritonavir Exports?

Port	Shipments	% Share
SAHAR AIR	335	21.5%
SAHAR AIR CARGO ACC (INBOM4)	281	18.1%
HYDERABAD ACC (INHYD4)	217	14.0%
HYDERABAD AIR	123	7.9%
Bombay Air	87	5.6%
NHAVA SHEVA SEA (INNSA1)	58	3.7%
DELHI AIR CARGO ACC (INDEL4)	48	3.1%
HYDERABAD ICD	47	3.0%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Ritonavir Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ritonavir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 550 individual customs records matching Mylan Laboratories Limited exporting Ritonavir, covering 312 formulations to 99 countries via 224 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 155+ countries, 525+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ritonavir

Ritonavir

Mylan Laboratories Limited — Ritonavir Exporter Profile

Mylan Laboratories Limited — Ritonavir Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Ritonavir?

Who Are the Top Buyers of Ritonavir from Mylan Laboratories Limited?

What Is India's Total Ritonavir Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Ritonavir Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Ritonavir Exporters?

What Ritonavir Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Ritonavir to Key Markets

South Africa — SAHPRA

Nigeria — NAFDAC

How Does Mylan Laboratories Limited Compare to Nearest Ritonavir Exporters?

Which Indian Ports Ship Ritonavir Exports?

What Other Antiviral & HIV Medications Products Does Mylan Laboratories Limited Export?

Ritonavir — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Ritonavir Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ritonavir Export Data from Mylan Laboratories Limited

Ritonavir Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source